CARGO Therapeutics (CRGX) Competitors

Cullinan Oncology (NASDAQ:CGEM) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking.

Is CGEM or CRGX more profitable?

Cullinan Oncology's return on equity of 0.00% beat CARGO Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cullinan Oncology	N/A	-32.11%	-30.39%
CARGO Therapeutics	N/A	N/A	N/A

Do institutionals & insiders hold more shares of CGEM or CRGX?

86.3% of Cullinan Oncology shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 8.8% of Cullinan Oncology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the media favor CGEM or CRGX?

In the previous week, Cullinan Oncology had 5 more articles in the media than CARGO Therapeutics. MarketBeat recorded 7 mentions for Cullinan Oncology and 2 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.51 beat Cullinan Oncology's score of 0.50 indicating that Cullinan Oncology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cullinan Oncology	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CARGO Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, CGEM or CRGX?

CARGO Therapeutics has lower revenue, but higher earnings than Cullinan Oncology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cullinan Oncology	$18.94M	57.53	-$153.16M	-$3.69	-6.86
CARGO Therapeutics	N/A	N/A	-$98.15M	N/A	N/A

Does the MarketBeat Community favor CGEM or CRGX?

Cullinan Oncology received 26 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 77.50% of users gave Cullinan Oncology an outperform vote.

Company	Underperform	Outperform
Cullinan Oncology	Outperform Votes 31 77.50%	Underperform Votes 9 22.50%
CARGO Therapeutics	Outperform Votes 5 100.00%	Underperform Votes No Votes

Do analysts prefer CGEM or CRGX?

Cullinan Oncology presently has a consensus price target of $28.75, suggesting a potential upside of 13.64%. CARGO Therapeutics has a consensus price target of $29.67, suggesting a potential upside of 58.82%. Given Cullinan Oncology's higher probable upside, analysts plainly believe CARGO Therapeutics is more favorable than Cullinan Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cullinan Oncology	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
CARGO Therapeutics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Cullinan Oncology and CARGO Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.